Profound Medical to Unveil Next TULSA-AI® Module, ‘UA Alignment Assistant'

Core Insights - Profound Medical Corp. has introduced its third TULSA-AI® software module, UA Alignment Assistant, aimed at enhancing the TULSA procedure for prostate treatment [1][5] - The TULSA procedure is positioned as a potential mainstream treatment for various prostate conditions, including prostate cancer and benign prostatic hyperplasia (BPH) [2][9] - The upcoming presentations at RSNA 2024 and SUO 2024 will showcase the efficacy and advancements of the TULSA procedure [5][7] Company Overview - Profound Medical Corp. is a commercial-stage medical device company focused on customizable, incision-free therapies for diseased tissue ablation [8] - The company is commercializing the TULSA-PRO® system, which integrates real-time MRI guidance and ultrasound technology for precise treatment [9][10] TULSA Procedure Details - The TULSA procedure utilizes real-time MR guidance to precisely target prostate tissue, heating it to 55-57°C without incisions or radiation [2][9] - It is designed to preserve urinary continence and sexual function, with a single-session treatment that typically requires no hospital stay [2][9] UA Alignment Assistant Software - The UA Alignment Assistant streamlines the alignment of the ultrasound applicator during the TULSA procedure, improving workflow consistency and reducing manual steps [4][5] - This software enhancement is expected to simplify the procedure for users, thereby increasing efficiency and confidence in clinical outcomes [3][5] Upcoming Presentations - The RSNA 2024 will feature multiple presentations on the TULSA procedure, including studies on its efficacy and patient outcomes [5][7] - Notable presentations will come from institutions such as the Busch Center, UT Southwestern Medical Center, and the Mayo Clinic [5][7]